Free Trial

Assura (LON:AGR) Stock Passes Above 200-Day Moving Average - Should You Sell?

Assura logo with Real Estate background

Shares of Assura Plc (LON:AGR - Get Free Report) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 45.47 ($0.61) and traded as high as GBX 50.55 ($0.68). Assura shares last traded at GBX 50.35 ($0.68), with a volume of 4,677,779 shares.

Assura Trading Down 0.7%

The company has a market capitalization of £1.63 billion, a PE ratio of -47.77, a PEG ratio of 3.60 and a beta of 0.37. The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.05. The stock has a fifty day moving average of GBX 49.80 and a two-hundred day moving average of GBX 45.78.

Assura (LON:AGR - Get Free Report) last released its earnings results on Monday, July 21st. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share for the quarter. Assura had a negative return on equity of 1.92% and a negative net margin of 18.09%. As a group, sell-side analysts anticipate that Assura Plc will post 3.5830389 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Jayne Cottam sold 94,230 shares of the company's stock in a transaction dated Tuesday, July 22nd. The shares were sold at an average price of GBX 50 ($0.67), for a total value of £47,115 ($63,318.10). Also, insider Jonathan Murphy bought 607 shares of Assura stock in a transaction dated Wednesday, July 9th. The stock was acquired at an average cost of GBX 50 ($0.67) per share, for a total transaction of £303.50 ($407.88). Insiders have acquired a total of 1,520 shares of company stock worth $75,694 in the last quarter. Company insiders own 8.35% of the company's stock.

About Assura

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served. We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G). Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.

Further Reading

Should You Invest $1,000 in Assura Right Now?

Before you consider Assura, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.

While Assura currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines